Daily non-political popular news in brief.

Tumors stopped from spreading to new sites

04-05-2007 · EurekAlert!

For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. Using a mouse model of breast cancer, researchers from Vanderbilt University have now generated evidence to suggest that treatment with TGF-beta inhibitors might help such patients.

Keywords: tumors, stopped, spreading, sites, tumor, site

« Previous | Next »

Similar news on "Tumors stopped from spreading to new sites":

JCI table of contents -- April 5, 2007
04-05-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, April 5, 2006, in the JCI, including: Tumors stopped from spreading to new sites; Leptin gives itself some negative feedback; Role for STARS in heart failure illuminated; Learning the normal functions of EWS; and To inhibit or not to inhibit Gi proteins in asthma?
Similar news · Read more »
Jefferson scientists find blood vessel-building protein halts blood vessels from forming in cancer
11-14-2006 · EurekAlert!
A piece of the protein cellular scaffolding involved in building blood vessels duringdevelopment might have the opposite effect in tumors. Scientists have found that the protein fragment endorepellin blocks both skin and lung cancer tumors from progressing in animal models by preventing their ability to recruit new blood vessels, a process called angiogenesis. The researchers believe the finding could lead to a new type of tumor inhibitor to prevent cancer from spreading.
Similar news · Read more »
Genetically modified cells attack tumors
12-21-2006 · EurekAlert!
Mice with neuroblastoma tumors have been successfully treated with genetically modified cells that sought out the cancer cells and activated a chemotherapy drug directly at those sites, according to investigators at St. Jude Children's Research Hospital and their colleagues at City of Hope National Medical Center (Duarte, Calif.) and the University of British Columbia (Vancouver, Canada). Neuroblastoma is a solid tumor that arises in the part of the nervous system outside the brain.
Similar news · Read more »
Reactivating a critical gene lost in kidney cancer reduces tumor growth
08-15-2007 · EurekAlert!
Researchers at Mayo Clinic Jacksonville, have found that a key gene is often "silenced" in clear cell renal cell carcinoma, the most common type of kidney cancer, and when they restored that gene in human kidney cancer cells in culture and animal experiments, tumors stopped growing and many disappeared.
Similar news · Read more »
JCI online early table of contents: Feb. 7, 2008
02-07-2008 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Feb. 7, 2008, in the JCI, including: VEGF-B helps nerve cells cheat death without unwanted side effects; The key to survival and virulence for a fungal pathogen is autophagy; Straight to the tumor: fusion protein targets iNKT immune cells to tumors; T cells stopped from reaching their destination; The soluble factor IL-10 has guts: and others.
Similar news · Read more »
Tenacious STD: Drug-resistant gonorrhea is spreading
04-21-2007 · Science News Online
Responding to a surge in tough-to-treat gonorrhea, the CDC has stopped recommending Cipro-class antibiotics for the disease.
Similar news · Read more »
Genomic 'firestorms' underlie aggressive breast cancer progression
11-30-2006 · EurekAlert!
The first high-resolution analysis of genomic alterations in breast tumors is reported in the scientific journal Genome Research. In this analysis, scientists from Cold Spring Harbor Laboratory, in collaboration with researchers from Scandinavia, identified three distinct patterns of genomic variation that underlie breast tumor formation, one of which -- "firestorms" -- may be predictive of aggressive disease progression and short survival.
Similar news · Read more »
Gene profiling predicts resistance to breast cancer drug Herceptin
02-20-2007 · EurekAlert!
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Similar news · Read more »
Therapeutic unshackles p53 and causes tumor regression
03-15-2007 · EurekAlert!
Infection with Kaposi's sarcoma virus (KSHV) can cause 3 types of tumor, including primary effusion lymphoma (PEL). Although KSHV has been known to cause tumors for many years, there are no effective therapies for KSHV-induced tumors. In a new study it is shown that the small-molecule inhibitor Nutlin-3a has antitumor effects in a mouse xenograft model of PEL, indicating that it might provide a viable therapeutic option for the treatment of individuals with PEL.
Similar news · Read more »
Analysis of breast and colon cancer genes finds many areas of differences between tumors
10-11-2007 · EurekAlert!
Researchers from University Hospitals Ireland Cancer Center and Case Western Reserve University School of Medicine are part of a new national study that has analyzed more than 18,000 genes, including 5,000 previously unmapped genes, from breast and colorectal tumors. The study shows a great number of genetic differences between breast and colon cancer tumors, leading the researchers to conclude that new drugs must be developed that can hit these newly identified genetic targets in a manner specific to each different individual's tumor.
Similar news · Read more »